Regenerative Engineering Society Establishes Award in Honor of MIMEDX Board Member, Dr. Cato T. Laurencin
MARIETTA, Ga., Aug. 26, 2022 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today recognized Board Member, Cato T. Laurencin, M.D., Ph.D. for his leadership and contributions to advance the field of regenerative engineering. The Cato T. Laurencin Regenerative Engineering Founders’ Award has been established by […]
What about Stem Cell Banking? Answers to Cord Blood Banking FAQs & More
Have you heard about cord blood banking, but aren’t quite sure what it is or why you’d want to consider it? Catch a news story about celebrities using regenerative stem cells and wonder what’s the big deal? This is the video for you! Benefits, Risks, and Alternatives of Stem Cell Collection BENEFITS – Security that […]
Prominent ophthalmologist will guide Turn Bio’s search for therapies to cure eye diseases
MOUNTAIN VIEW, Calif., Aug. 22, 2022 /PRNewswire/ — Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that Albert Wu, MD, PhD, will oversee its development of ophthalmic therapeutic products as an advisor to the company. A board-certified ophthalmologist and fellowship-trained specialist in oculoplastic and orbital surgery, […]
Regenerative Medicine: The New Frontier in Healing with Special Guest Dr. Stuart Kauffman, DO
In this episode of Dr. Smith Live, Dr. Stuart Kauffman is the featured guest and shares some great information regarding today’s use of regenerative medicine. Topics discussed include: • Incredible regenerative effect of stem cells • Advantages of using growth factor with stem cell treatment • Best ways to treat sport injuries without drugs • […]
Immunis Announces FDA Clearance and Clinical Site for Phase 1/2a Clinical Trial Investigating Immune-Mediated Muscle Atrophy
IRVINE, Calif., Aug. 9, 2022 /PRNewswire/ — Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, today announced that the U.S. Food and Drug Administration has approved it’s Investigational New Drug application for a Phase 1/2a clinical trial investigating IMM01-STEM in participants with muscle atrophy: www.clinicaltrials.gov/ct2/show/NCT05211986 The open label […]
Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio
MOUNTAIN VIEW, Calif., Aug. 8, 2022 /PRNewswire/ — Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that co-founder Vittorio Sebastiano, PhD, will become its head of research. Sebastiano led development of the unique mRNA-based ERA™ (Epigenetic Reprogramming of Aging) platform Turn Bio uses to produce tailored […]
Global Mesenchymal Stem Cells Market Intelligence Report 2022: Industry to reach $5.84 Billion by 2027
Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) — The “Mesenchymal Stem Cells Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Mesenchymal Stem Cells Market is projected to reach USD 5,847.88 million by 2027 from USD 2,731.51 million in 2021, at a CAGR 13.52% during the forecast period. […]
Why Are Stem Cells The Future Of Medicine
Why do stem cells matter for the future of medicine? NYSCF’s Senior Vice President of Research Scott Noggle, PhD dives into the basics of stem cell research and what it means for diseases like Alzheimer’s, macular degeneration, and ALS. Watch Dr. Noggle’s full presentation here.
Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study
PHOENIX, July 28, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced positive three-year follow up data for the Company’s OvaStem® pilot study. The data shows significant efficacy of […]
5 Things Doctors Get Wrong and 5 Myths About Stem Cell Therapy With Dr. Joy Kong
Stem cells! There are a lot of myths out there about stem cell therapy and there are also some things that even doctors get wrong about it. Dr. Joy Kong, M.D. talks about 5 things doctors get wrong and 5 myths about stem cell therapy. *** All content on NationalStemCellTherapy.com is for informational purposes only. […]